US Codex
Bill
Notes

Practitioner Enforcement and Tracking of Substances Act

H.R. 8983 · 119th Congress · May 21, 2026 · Lineage

A BILL

To increase compliance with PDMP requirements by veterinarians, and for other purposes.

Section 1 Short title

This Act may be cited as the “Practitioner Enforcement and Tracking of Substances Act” or the “PETS Act”.

Sec. 2 Increasing compliance with PDMP requirements

(a)
Increasing compliance by veterinarians—
(1)
In general— Section 399O(h)(1) of the Public Health Service Act (42 U.S.C. 280g–3(h)(1)) is amended—
(A)
by striking “Nothing in this section” and inserting the following:

“(1) In general—Except as specified in paragraph (2), nothing in this section”

(B)
by adding at the end the following:

“(2) Veterinary patients

“(A) In general—Paragraph (1) shall not apply with respect to the authority of a State to prohibit reporting to the PDMP of the dispensing of a controlled substance to a minor patient, if—

“(i) the prescribing or dispensing practitioner is a veterinarian licensed in such State; and

“(ii) the patient to whom the controlled substance is prescribed or dispensed is a veterinary patient.

“(B) Information to be reported—A veterinarian described in subparagraph (A) shall report to the PDMP, in lieu of information required under this section relating to the veterinary patient involved, such information relating to the owner or primary caretaker of the veterinary patient.”

(2)
Definition of dispenser— Section 399O(k)(3) of the Public Health Service Act (42 U.S.C. 280g–3(k)(3)) is amended by striking “physician,” and inserting “physician, veterinarian,”.
(3)
Sense of Congress— It is the sense of Congress that, notwithstanding State law, a veterinarian is required to comply with the requirements of section 399O of the Public Health Service Act (42 U.S.C. 280g–3) with respect to consulting the PDMP (as defined in section 399O(k) of the Public Health Service Act (42 U.S.C. 280g–3(k))) prior to prescribing any controlled substance, and reporting any dispensing of a controlled substance to the PDMP to the same extent as any other practitioner (as defined in subsection (k) of such section) is required to comply with such requirements.
(b)
Reporting of non-Fatal overdoses— Section 399O(b) of the Public Health Service Act (42 U.S.C. 280g–3(b)) is amended—
(1)
in paragraph (5), by striking “and” at the end;
(2)
in paragraph (6), by striking the period at the end and inserting “; and”; and
(3)
by adding at the end the following:

“(7) the reporting to the PDMP by each prescribing or dispensing practitioner, or their designee, of any instance of a non-fatal overdose event that required intervention by such practitioner (or designee), not later than 72 hours after such overdose event occurred.”

(c)
Drug misuse and abuse— Section 399O(c)(2) of the Public Health Service Act (42 U.S.C. 280g–3(c)(2)) is amended by striking “may” and inserting “shall”.